Theravance Biopharma, Inc. (TBPH)
16.49
+0.20
(+1.23%)
USD |
NASDAQ |
Jun 09, 16:00
16.49
0.00 (0.00%)
After-Hours: 18:54
Theravance Biopharma SG&A Expense (Quarterly) : 20.17M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Viatris, Inc. | 928.80M |
| Indivior Pharmaceuticals, Inc. | 124.00M |
| Relmada Therapeutics, Inc. | 11.37M |
| Corcept Therapeutics, Inc. | 145.36M |
| Assertio Holdings, Inc. | 11.14M |